These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

123 related items for PubMed ID: 406677

  • 21. Methodological aspects of the 6-day subrenal capsule assay for measuring the response of human tumors to anticancer agents.
    Aamdal S, Fodstad O, Pihl A.
    Anticancer Res; 1985; 5(4):329-37. PubMed ID: 4037730
    [Abstract] [Full Text] [Related]

  • 22. Phase I study of weekly maytansine given by iv bolus or 24-hour infusion.
    Chahinian AP, Nogeire C, Ohnuma T, Greenberg ML, Sivak M, Jaffrey IS, Holland JF.
    Cancer Treat Rep; 1979; 63(11-12):1953-60. PubMed ID: 526928
    [No Abstract] [Full Text] [Related]

  • 23. Phase I and clinical pharmacology trial of crisnatol (BWA770U mesylate) using a monthly single-dose schedule.
    Harman GS, Craig JB, Kuhn JG, Luther JS, Turner JN, Weiss GR, Tweedy DA, Koeller J, Tuttle RL, Lucas VS.
    Cancer Res; 1988 Aug 15; 48(16):4706-10. PubMed ID: 3396016
    [Abstract] [Full Text] [Related]

  • 24. [The toxicity and pharmacologic properties of rifampicin].
    Gol'dberg LE, Stepanova ES, Muraveĭskaia VS, Belova IP, Vertogradova TP.
    Antibiotiki; 1974 May 15; 19(5):427-32. PubMed ID: 4463882
    [No Abstract] [Full Text] [Related]

  • 25. [Phase I clinical study of antineoplastic agents].
    Majima H.
    Gan To Kagaku Ryoho; 1991 Jul 15; 18(9):1487-91. PubMed ID: 1854219
    [Abstract] [Full Text] [Related]

  • 26. Quantitative prediction of drug toxicity in humans from toxicology in small and large animals.
    Goldsmith MA, Slavik M, Carter SK.
    Cancer Res; 1975 May 15; 35(5):1354-64. PubMed ID: 804350
    [Abstract] [Full Text] [Related]

  • 27. Complications of cytotoxic antineoplastic chemotherapy.
    White DR, Cooper MR, Muss HB, Richards F, Spurr CL.
    N C Med J; 1979 Feb 15; 40(2):73-8. PubMed ID: 370616
    [No Abstract] [Full Text] [Related]

  • 28. Toxic effects of cis-dichlorodiammineplatinum(II) in man.
    Von Hoff DD, Schilsky R, Reichert CM, Reddick RL, Rozencweig M, Young RC, Muggia FM.
    Cancer Treat Rep; 1979 Feb 15; 63(9-10):1527-31. PubMed ID: 387223
    [Abstract] [Full Text] [Related]

  • 29. Chemotherapy research nurse.
    Hubbard S, Devita V.
    Am J Nurs; 1976 Apr 15; 76(4):560-5. PubMed ID: 818899
    [No Abstract] [Full Text] [Related]

  • 30. Toxicity of aziridinylbenzoquinone administered Iv to beagle dogs.
    Hacker MP, Hong CB, McKee MJ, Unwin SE, Urbanek MA.
    Cancer Treat Rep; 1982 Oct 15; 66(10):1845-51. PubMed ID: 7127322
    [No Abstract] [Full Text] [Related]

  • 31. [Chemotherapy in the elderly].
    Furue H.
    Gan To Kagaku Ryoho; 1992 Sep 15; 19(11):1796-800. PubMed ID: 1519923
    [Abstract] [Full Text] [Related]

  • 32. Clinical trials with diglycoaldehyde (NSC-118994): review and reasons for withdrawal from clinical trial.
    Chiuten DF, Vosika GJ, Shaw MT, Boiron M, Gisselbrecht C, Marty M, Higgins G, Muggia FM.
    Anticancer Res; 1981 Sep 15; 1(2):121-4. PubMed ID: 7347155
    [Abstract] [Full Text] [Related]

  • 33. [The nurse's role in cytostatic treatment of cancer patients].
    Simonetti G, Dreschler JM, Somers R.
    Tijdschr Ziekenverpl; 1980 Mar 11; 33(6):239-49. PubMed ID: 6770488
    [No Abstract] [Full Text] [Related]

  • 34. [The importance of controlling the side effects of antineoplastic therapy with cisplatin].
    Ringborg U.
    Lakartidningen; 1983 May 25; 80(21):2240-1. PubMed ID: 6683773
    [No Abstract] [Full Text] [Related]

  • 35. Preclinical toxicity studies of kahalalide F, a new anticancer agent: single and multiple dosing regimens in the rat.
    Brown AP, Morrissey RL, Faircloth GT, Levine BS.
    Cancer Chemother Pharmacol; 2002 Oct 25; 50(4):333-40. PubMed ID: 12357309
    [Abstract] [Full Text] [Related]

  • 36. Phase I study to determine the safety and pharmacokinetics of oral administration of TAS-102 in patients with solid tumors.
    Hong DS, Abbruzzese JL, Bogaard K, Lassere Y, Fukushima M, Mita A, Kuwata K, Hoff PM.
    Cancer; 2006 Sep 15; 107(6):1383-90. PubMed ID: 16902987
    [Abstract] [Full Text] [Related]

  • 37. Toxicology studies with d-tetrandrine (NSC-77037), a plant alkaloid with vascular and lymphotoxic effects in dogs and monkeys.
    Gralla EJ, Coleman GL, Jonas AM.
    Cancer Chemother Rep 3; 1974 Sep 15; 5(1):79-85. PubMed ID: 4213510
    [No Abstract] [Full Text] [Related]

  • 38. [Preclinical and clinical evaluation of toxicity and antitumor activity of cisplatin analogues].
    Ariyoshi Y, Ota K.
    Gan To Kagaku Ryoho; 1989 Apr 15; 16(4 Pt 2-2):1379-85. PubMed ID: 2658826
    [Abstract] [Full Text] [Related]

  • 39. Predictive value of preclinical toxicology studies for platinum anticancer drugs.
    Clark DL, Andrews PA, Smith DD, DeGeorge JJ, Justice RL, Beitz JG.
    Clin Cancer Res; 1999 May 15; 5(5):1161-7. PubMed ID: 10353752
    [Abstract] [Full Text] [Related]

  • 40. Antitumor drug toxicity: implications for response and for survival.
    Nahhas WA, Hall TC, Sherman CD, Savlov ED.
    Am J Med Sci; 1969 Oct 15; 258(4):245-59. PubMed ID: 5823461
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.